LGND
Ligand Pharmaceuticals Inc
Price:  
72.37 
USD
Volume:  
93,874.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND Relative Valuation

-64.1%
Upside

As of 2024-02-21, the Relative Valuation of Ligand Pharmaceuticals Inc (LGND) is 25.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 72.37 USD, the upside of Ligand Pharmaceuticals Inc based on Relative Valuation is -64.1%.

The range of the Relative Valuation is 22.79 - 29.48 USD.

Range Selected
Trailing P/E multiples 25.8x - 31.2x 28.5x
Forward P/E multiples 21.9x - 26.1x 24.0x
Fair Price 22.79 - 29.48 25.95
Upside -68.5% - -59.3% -64.1%
72.37 USD
Stock Price
25.95 USD
Fair Price

LGND Relative Valuation - Historical P/E Data

Date P/E
2024-02-21 76.27
2024-02-20 76.59
2024-02-16 77.95
2024-02-15 79.00
2024-02-14 77.91
2024-02-13 75.14
2024-02-12 80.05
2024-02-09 80.30
2024-02-08 79.80
2024-02-07 78.85
2024-02-06 79.70
2024-02-05 79.07
2024-02-02 78.88
2024-02-01 78.49
2024-01-31 77.36
2024-01-30 78.22
2024-01-29 79.43
2024-01-26 80.90
2024-01-25 79.68
2024-01-24 78.49
2024-01-23 77.85
2024-01-22 77.67
2024-01-19 76.74
2024-01-18 75.38
2024-01-17 74.99
2024-01-16 75.21
2024-01-12 76.83
2024-01-11 76.40
2024-01-10 77.82
2024-01-09 77.73
2024-01-08 78.68
2024-01-05 74.96
2024-01-04 74.46
2024-01-03 74.12
2024-01-02 76.52
2023-12-29 75.58
2023-12-28 76.02
2023-12-27 76.49
2023-12-26 76.86
2023-12-22 75.68
2023-12-21 74.96
2023-12-20 73.37
2023-12-19 74.32
2023-12-18 73.23
2023-12-15 71.27
2023-12-14 71.65
2023-12-13 71.20
2023-12-12 66.61
2023-12-11 66.18
2023-12-08 65.42